Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 70 Prostatic Neoplasms 50 Multiple Myeloma 30 Neoplasm Metastasis 28 Osteoporosis 16 Pain 15 Carcinoma, Non-Small-Cell Lung 11 Neoplasms 10 Lung Neoplasms 8 Osteosarcoma 7 Neoplasms, Plasma Cell 7 Neuroblastoma 6 Carcinoma, Renal Cell 6 Bone Diseases, Metabolic 6 Humoral Hypercalcemia Of Malignancy 5 Bone Neoplasms 5 Fractures, Bone 4 Bone Diseases 4 Triple Negative Breast Neoplasms 3 Sarcoma, Ewing 3 Sarcoma 3 Lymphoma 3 Kidney Neoplasms 3 Uterine Cervical Neoplasms 2 Spinal Cord Compression 2 Small Cell Lung Carcinoma 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Ovarian Neoplasms 2

Interventions

Doxorubicin 25 Gemcitabine 16 Trabectedin 12 Ifosfamide 12 Radiotherapy 11 Docetaxel 10 Dacarbazine 8 pazopanib 7 Nivolumab 6 Specimen Handling 5 Biopsy 5 liposomal doxorubicin 4 Temozolomide 4 pembrolizumab 3 Sunitinib 3 Sorafenib 3 Radiation 3 Magnetic Resonance Spectroscopy 3 Filgrastim 3 rucaparib 2 pegfilgrastim 2 olaratumab 2 eribulin 2 durvalumab 2 cixutumumab 2 cemiplimab 2 brostallicin 2 belinostat 2 avelumab 2 X-Rays 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyosarcoma × Zoledronic Acid × Clear all

NCT05080790 2025-08-17

DiTuSarc

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡